CVS MEDICARE ANALYTICS & INSIGHTS TOOL
Live / Applied — Fourth extension granted (statement of use) (as of 22 Apr 2025)
What this means for you
Not registered yet, but its 23 Jun 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97472120
- Mark type
- Stylized text
- Filed
- 23 Jun 2022
- Published for opposition
- 11 Apr 2023
- Attorney of record
- Erich G. Rhynhart
Goods and services
- Class 035 — Advertising and business services: Providing a website and online portal featuring aggregated pharmaceutical and medical claims data for market research purposes; Providing a website and online portal featuring aggregated Medicare claims data, competitive market share data, claims documents and invoices for pharmaceutical manufacturer market research
- Class 042 — Scientific and technological services: Providing a website and online portal featuring aggregated pharmaceutical and medical claims data for medical and scientific research; Providing a website featuring technology that enables users to view aggregated Medicare claims data, competitive market share data and to share claims documents and invoices with pharmaceutical manufacturers
Owner
- CVS Pharmacy, Inc., Woonsocket, RI, US
- CVS Pharmacy, Inc., Woonsocket, RI, US
Prior registrations
Prosecution history
- 19 Nov 2025 — TEAS STATEMENT OF USE RECEIVED
- 23 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Apr 2025 — SOU EXTENSION 4 GRANTED
- 22 Apr 2025 — SOU EXTENSION 4 FILED
- 22 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 31 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Oct 2024 — SOU EXTENSION 3 GRANTED
- 31 Oct 2024 — SOU EXTENSION 3 FILED
- 31 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 18 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Apr 2024 — SOU EXTENSION 2 GRANTED
- 17 Apr 2024 — SOU EXTENSION 2 FILED
- 17 Apr 2024 — SOU TEAS EXTENSION RECEIVED
- 11 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Nov 2023 — SOU EXTENSION 1 GRANTED